Comparison of the efficiency of 12 mg and 18 mg adenosine in terminating supraventricular tachycardias;Terminierung supraventrikularer tachykardien durch adenosin - Vergleich der wirkung von 12 mg und 18 mg

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 33, 2000, Pages 961-969

  Weismuller, P ^a   Kattenbeck, K ^a   Heinroth, K M ^b   Ranke, C ^a   Trappe, H J ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; REENTRY TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART PACING; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROSPECTIVE STUDY;

ADENOSINE; ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, ECTOPIC ATRIAL; TACHYCARDIA, SUPRAVENTRICULAR; TREATMENT OUTCOME;

EID: 0034682690     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7002     Document Type: Article

References (23)

1. Ventricular fibrillation following adenosine administration
2. Adenosine and supraventricular tachycardia
3. Adenosine: Electrophysiologic effects and therapeutic use for terminating paroxsysmal supraventricular tachyardia
4. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias
5. Adenosine for paroxysmal supraventricular tachycardia: Dose ranging and comparison with verapamil
6. Effects of adenosine and adenosine-5-triphosphate on atrioventricular conduction in patients with supraventricular tachycardias
7. Electrophysiologic effects of adenosine in patients with supraventricular tachycardia
8. The action of adenosine upon the human heart
9. Three forms of atrioventricular nodal (junctional) reentrant tachycardia: Differential diagnosis, electrophysiological characteristics, and implications for anatomy of the reentrant circuit
10. Use of adenosine in patients hospitalized in a university medical center
11. Verapamil in the treatment of paroxysmal supraventricular tachycardia
12. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias
13. Adenosine or adenosine triphosphate for supraventricular tachycardia? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias
14. Immediate effects of intravenous verapamil in cardiac arrhythmias
15. Adenosine induced atrial arrhythmias: A prospective analysis
16. Intravenous adenosine during atrioventricular reentrant tachycardia: Induction of atrial fibrillation with rapid conduction over an accessory pathway
17. Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children
18. Akuttherapie supraventrikularer Tachykardien: Adenosin oder Ajmalin?
19. Acute management of paroxysmal atrioventricular junctional reentrant supraventricular tachycardia: Pharmacologic strategies
20. Ungewohnli-che Tachykardien bei einem 27-jahrigen Dachdecker
21. Induktion von vorhofflimmern dutch adenosin bei einem patienten mit supraventrikularer tachykardie
22. Specific arrhythmias: Diagnosis and treatment